Skip to main content

Table 1 South Korean governmental research funds for 25 types of cancer in 2005–2017

From: The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research

CancerNumber of research projectsa (% of total)Sum of funding amount (USD) (% of total)Mean (SD)Median (IQR)Max. of funding amount (USD)Min. of funding amount (USD)
Bladder cancer224 (1.3)45,175,920 (1.6)201,678 (413,219)54,152 (43,054–172,356)3,092,1426279
Brain and nervous system cancer208 (1.2)41,801,454 (1.5)200,969 (428,524)75,958 (46,126–150,727)3,092,1424419
Breast cancer3012 (17.4)507,877,006 (18.3)168,618 (388,459)61,022 (43,445–155,674)12,317,6324308
Cervical cancer476 (2.8)67,038,896 (2.4)140,838 (332,582)73,006 (43,085–135,808)4,842,8765484
Colon and rectum cancer2253 (13.0)359,683,255 (13.0)159,646 (281,421)66,322 (43,318–156,691)4,369,7114305
Oesophageal cancer89 (0.5)24,725,583 (0.9)277,816 (817,180)51,891 (39,173–73,057)3,670,5664419
Gallbladder and biliary tract cancer140 (0.8)22,411,781 (0.8)160,084 (216,101)59,738 (42,893–130,102)902,4379024
Kidney cancer153 (0.9)16,967,505 (0.6)110,899 (142,109)53,058 (43,085–91,051)723,8266834
Larynx cancer16 (0.1)1,531,930 (0.1)95,746 (127,238)47,196 (24,748–97,779)542,8043905
Leukaemia698 (4.0)78,708,162 (2.8)112,762 (184,828)53,874 (41,995–107,246)1,917,9284419
Lip and oral cavity cancer277 (1.6)30,685,586 (1.1)110,778 (173,473)51,891 (43,085–88,958)1,335,5579024
Liver cancer2121 (12.3)359,910,785 (13.0)169,689 (310,499)82,263 (45,842–150,331)3,092,1423610
Malignant skin melanoma326 (1.9)53,382,377 (1.9)163,750 (747,416)47,655 (40,813–89,339)13,058,8848843
Mesothelioma20 (0.1)1,404,068 (0.1)70,203 (64,989)42,134 (38,140–57,361)246,8627533
Multiple myeloma134 (0.8)18,070,326 (0.7)134,853 (360,193)56,592 (43,796–106,566)3,892,8247032
Nasopharynx cancer5 (0.03)538,418 (0.02)107,684 (82,799)68,936 (36,278–165,965)240,70926,529
Non-Hodgkin lymphoma287 (1.7)37,178,554 (1.3)129,542 (249,306)63,487 (44,208–130,912)3,388,5116834
Other pharynx cancer4 (0.02)315,457 (0.01)78,864 (69,995)55,689 (18,967–115,586)188,38115,698
Ovarian cancer619 (3.6)75,159,865 (2.7)121,421 (198,334)53,812 (42,097–98,950)2,044,7705484
Pancreatic cancer519 (3.0)89,509,485 (3.2)172,465 (237,389)73,691 (43,946–192,220)1,658,0596834
Prostate cancer886 (5.1)138,598,295 (5.0)156,431 (330,671)54,416 (43,318–118,166)4,203,5541204
Stomach cancer2022 (11.7)299,360,928 (10.8)148,052 (256,031)58,929 (43,226–141,070)2,928,4404421
Testicular cancer9 (0.1)504,503 (0.02)56,056 (29,089)46,620 (40,740–68,339)104,65618,019
Thyroid cancer246 (1.4)26,851,359 (1.0)109,152 (180,892)53,002 (43,709–94,947)1,541,8244419
Tracheal, bronchus and lung cancer2550 (14.7)470,609,400 (17.0)184,553 (385,722)70,744 (44,292–160,571)5,541,5433889
  1. aMultiple counting was allowed for the research projects that can be utilised in several types of cancers, accounting for 38.9% of the total number of research projects